ACS Medicinal Chemistry Letters

Papers
(The TQCC of ACS Medicinal Chemistry Letters is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2168
Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment139
Solution Conformations Shed Light on PROTAC Cell Permeability95
Understanding and Improving the Membrane Permeability of VH032-Based PROTACs80
Visible-Light Photocatalysis as an Enabling Technology for Drug Discovery: A Paradigm Shift for Chemical Reactivity67
The Advent of Generative Chemistry65
Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity61
A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin53
Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space51
Ultra-High-Throughput Acoustic Droplet Ejection-Open Port Interface-Mass Spectrometry for Parallel Medicinal Chemistry47
Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation47
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors46
Biotransformation: Impact and Application of Metabolism in Drug Discovery45
Decarboxylative Cross-Coupling: A Radical Tool in Medicinal Chemistry41
Risdiplam, the First Approved Small Molecule Splicing Modifier Drug as a Blueprint for Future Transformative Medicines41
Evaluation of 3-Dimensionality in Approved and Experimental Drug Space41
Systematic Investigation of the Permeability of Androgen Receptor PROTACs41
Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency39
The Growing Importance of Chirality in 3D Chemical Space Exploration and Modern Drug Discovery Approaches for Hit-ID38
Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors38
Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate36
Folate Receptor Targeting and Cathepsin B-Sensitive Drug Delivery System for Selective Cancer Cell Death and Imaging32
Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists32
Simultaneous Inhibition of SIRT2 Deacetylase and Defatty-Acylase Activities via a PROTAC Strategy31
Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)30
Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain29
Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia29
Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies28
Influence of Linker Attachment Points on the Stability and Neosubstrate Degradation of Cereblon Ligands27
Complex Crystal Structures of EGFR with Third-Generation Kinase Inhibitors and Simultaneously Bound Allosteric Ligands27
Establishing the Structure–Activity Relationship of Daptomycin27
Blocking Coronavirus 19 Infection via the SARS-CoV-2 Spike Protein: Initial Steps27
Discovery of Highly Selective and Potent HDAC3 Inhibitors Based on a 2-Substituted Benzamide Zinc Binding Group26
Emerging Chromatography-Free High-Throughput Mass Spectrometry Technologies for Generating Hits and Leads26
Asymmetrically Substituted Quadruplex-Binding Naphthalene Diimide Showing Potent Activity in Pancreatic Cancer Models26
Benzoxaboroles: New Potent Inhibitors of the Carbonic Anhydrases of the Pathogenic Bacterium Vibrio cholerae25
Discovery of Dotinurad (FYU-981), a New Phenol Derivative with Highly Potent Uric Acid Lowering Activity25
Rational Control of Molecular Properties Is Mandatory to Exploit the Potential of PROTACs as Oral Drugs25
SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression24
Trends in Hit-to-Lead Optimization Following DNA-Encoded Library Screens24
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting Del19/T790M/C797S Mutation24
Intriguing Antiviral Modified Nucleosides: A Retrospective View into the Future Treatment of COVID-1924
Trisubstituted Pyrrolinones as Small-Molecule Inhibitors Disrupting the Protein–RNA Interaction of LIN28 and Let-724
On the Selectivity of Heparan Sulfate Recognition by SARS-CoV-2 Spike Glycoprotein24
Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)24
Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington’s Disease23
Design, Synthesis, and Biological Evaluation of IRAK4-Targeting PROTACs23
A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir23
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation23
GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family23
Beyond 20 in the 21st Century: Prospects and Challenges of Non-canonical Amino Acids in Peptide Drug Discovery22
Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series22
Peripherally Crowded Cationic Phthalocyanines as Efficient Photosensitizers for Photodynamic Therapy22
2-Cyanoisonicotinamide Conjugation: A Facile Approach to Generate Potent Peptide Inhibitors of the Zika Virus Protease21
Exploring the Chemical Space of Benzothiazole-Based DNA Gyrase B Inhibitors21
De-risking Drug Discovery of Intracellular Targeting Peptides: Screening Strategies to Eliminate False-Positive Hits21
Discovery of Investigational Drug CT1812, an Antagonist of the Sigma-2 Receptor Complex for Alzheimer’s Disease20
Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance20
Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 120
Chemical Modification of Linkers Provides Stable Linker–Payloads for the Generation of Antibody–Drug Conjugates20
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds19
Contemporary Computational Applications and Tools in Drug Discovery19
Phosphoramidate Prodrugs Continue to Deliver, The Journey of Remdesivir (GS-5734) from RSV to SARS-CoV-219
Development of a Hematopoietic Prostaglandin D Synthase-Degradation Inducer19
GPCR Inhibition in Treating Lymphoma19
Discovery of GNE-149 as a Full Antagonist and Efficient Degrader of Estrogen Receptor alpha for ER+ Breast Cancer19
ONO-8430506: A Novel Autotaxin Inhibitor That Enhances the Antitumor Effect of Paclitaxel in a Breast Cancer Model18
Pilot Study to Quantify Palladium Impurities in Lead-like Compounds Following Commonly Used Purification Techniques18
Dioxane-Linked Amide Derivatives as Novel Bacterial Topoisomerase Inhibitors against Gram-Positive Staphylococcus aureus18
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry18
Novel Betulinic Acid–Nucleoside Hybrids with Potent Anti-HIV Activity18
Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist18
Discovery of Spiro-azaindoline Inhibitors of Hematopoietic Progenitor Kinase 1 (HPK1)18
Structural Approach to Assessing the Innovativeness of New Drugs Finds Accelerating Rate of Innovation18
Design and Implementation of Synthetic RNA Binders for the Inhibition of miR-21 Biogenesis18
Development of Potent and Selective Janus Kinase 2/3 Directing PG–PROTACs17
Development of a Potent Brain-Penetrant EGFR Tyrosine Kinase Inhibitor against Malignant Brain Tumors17
mRNA Display Reaches for the Clinic with New PCSK9 Inhibitor17
Design, Synthesis, and Biological Evaluation of Novel Acylhydrazone Derivatives as Potent Neuraminidase Inhibitors17
Development of Chimeric Molecules That Degrade the Estrogen Receptor Using Decoy Oligonucleotide Ligands17
Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity17
Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine Acetylation17
Cell Permeability of Isomeric Macrocycles: Predictions and NMR Studies17
Antiferroptotic Activity of Phenothiazine Analogues: A Novel Therapeutic Strategy for Oxidative Stress Related Disease17
BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate17
Identification of Potent Reverse Indazole Inhibitors for HPK117
Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors17
Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10)16
Discovery and Preclinical Evaluation of BMS-986242, a Potent, Selective Inhibitor of Indoleamine-2,3-dioxygenase 116
Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein16
Rapid Evaluation of Small Molecule Cellular Target Engagement with a Luminescent Thermal Shift Assay16
Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B16
From Bacteria to Cancer: A Benzothiazole-Based DNA Gyrase B Inhibitor Redesigned for Hsp90 C-Terminal Inhibition16
Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors16
Synthesis, Inhibitory Activity, and In Silico Modeling of Selective COX-1 Inhibitors with a Quinazoline Core16
Physicochemistry of Cereblon Modulating Drugs Determines Pharmacokinetics and Disposition16
Design and Synthesis of 1,2-Deoxy-pyranose Derivatives of Spliceostatin A toward Prostate Cancer Treatment16
Influence of 4′-Substitution on the Activity of Gemcitabine and Its ProTide Against VZV and SARS-CoV-216
Challenges and Opportunities for Drug Discovery in Developing Countries: The Example of Cutaneous Leishmaniasis16
Discovery of Tricyclic Xanthines as Agonists of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR1816
Synthesis, Biological Evaluation, and Molecular Docking of Arylpyridines as Antiproliferative Agent Targeting Tubulin15
Toward the Target: Tilorone, Quinacrine, and Pyronaridine Bind to Ebola Virus Glycoprotein15
Covalent Inhibition of Wild-Type HIV-1 Reverse Transcriptase Using a Fluorosulfate Warhead15
Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors15
Amide Tethered 4-Aminoquinoline-naphthalimide Hybrids: A New Class of Possible Dual Function Antiplasmodials15
Contemporary Progress and Opportunities in RNA-Targeted Drug Discovery14
Novel Blocker of Onco SK3 Channels Derived from Scorpion Toxin Tamapin and Active against Migration of Cancer Cells14
Antivirals against (Re)emerging Flaviviruses: Should We Target the Virus or the Host?14
Synthesis of C6-Substituted Purine Nucleoside Analogues via Late-Stage Photoredox/Nickel Dual Catalytic Cross-Coupling14
A Chemical Probe for the Methyl Transferase PRMT5 with a Novel Binding Mode14
Discovery of a First-in-Class Inhibitor of the Histone Methyltransferase SETD2 Suitable for Preclinical Studies14
Semisynthetic Analogs of the Antibiotic Fidaxomicin—Design, Synthesis, and Biological Evaluation14
A Green-Absorbing, Red-Fluorescent Phenalenone-Based Photosensitizer as a Theranostic Agent for Photodynamic Therapy14
Discovery and Development of Cyclic Peptide Inhibitors of CIB114
Virtual Screening for Ligand Discovery at the σ1 Receptor14
Computer Prediction of pKa Values in Small Molecules and Proteins14
DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry14
Structural Basis for Targeting the Folded P-Loop Conformation of c-MET14
Advancing New Chemical Modalities into Clinical Studies14
1,5-Disubstituted 1,2,3-Triazoles as Amide Bond Isosteres Yield Novel Tumor-Targeting Minigastrin Analogs14
Synthesis of Novel Ciprofloxacin-Based Hybrid Molecules toward Potent Antimalarial Activity13
Discovery of Vixotrigine: A Novel Use-Dependent Sodium Channel Blocker for the Treatment of Trigeminal Neuralgia13
Bioisostere Effects on the EPSA of Common Permeability-Limiting Groups13
Bromocriptine as a Novel Pharmacological Chaperone for Mucopolysaccharidosis IV A13
Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay13
Structural Basis for Activation of Human Sirtuin 6 by Fluvastatin13
Dual Glycolate Oxidase/Lactate Dehydrogenase A Inhibitors for Primary Hyperoxaluria13
meso-Thiophenium Porphyrins and Their Zn(II) Complexes: A New Category of Cationic Photosensitizers13
Thiol- and Disulfide-Containing Vancomycin Derivatives Against Bacterial Resistance and Biofilm Formation13
Hepatoselective Dihydroquinolizinone Bis-acids for HBsAg mRNA Degradation13
Ugi Reaction Synthesis of Oxindole–Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors13
Dual Reversible Coumarin Inhibitors Mutually Bound to Monoamine Oxidase B and Acetylcholinesterase Crystal Structures13
Brain Penetrable Inhibitors of Ceramide Galactosyltransferase for the Treatment of Lysosomal Storage Disorders13
Conjugation of a Blood Brain Barrier Peptide Shuttle to an Fc Domain for Brain Delivery of Therapeutic Biomolecules13
Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease13
Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors13
Semisynthetic Derivatives of the Verticillin Class of Natural Products through Acylation of the C11 Hydroxy Group13
Determination of Slow-Binding HDAC Inhibitor Potency and Subclass Selectivity13
Site-specific Incorporation of 2′,5′-Linked Nucleic Acids Enhances Therapeutic Profile of Antisense Oligonucleotides13
Structural Basis for Inhibition of Mutant EGFR with Lazertinib (YH25448)12
Novel Tricyclic Pyroglutamide Derivatives as Potent RORγt Inverse Agonists Identified using a Virtual Screening Approach12
Triazine-Based Covalent DNA-Encoded Libraries for Discovery of Covalent Inhibitors of Target Proteins12
Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase12
Automation of Synthesis in Medicinal Chemistry: Progress and Challenges12
Design, Synthesis, and Evaluation of PD-1/PD-L1 Antagonists Bearing a Benzamide Scaffold12
Macrocyclic Peptides as a Novel Class of NNMT Inhibitors: A SAR Study Aimed at Inhibitory Activity in the Cell12
Novel Copper(II) Complex with a 4-Acylpyrazolone Derivative and Coligand Induce Apoptosis in Liver Cancer Cells12
Role of Fluorination in the Histone Deacetylase 6 (HDAC6) Selectivity of Benzohydroxamate-Based Inhibitors12
Conversion of a PROTAC Mutant Huntingtin Degrader into Small-Molecule Hydrophobic Tags Focusing on Drug-like Properties12
Fueling the Pipeline via Innovations in Organic Synthesis12
Design and Synthesis of TRAP1 Selective Inhibitors: H-Bonding with Asn171 Residue in TRAP1 Increases Paralog Selectivity12
Discovery of a Series of Pyrazinone RORγ Antagonists and Identification of the Clinical Candidate BI 73035712
Studying Histone Deacetylase Inhibition and Apoptosis Induction of Psammaplin A Monomers with Modified Thiol Group12
Structural Basis of Inhibition of Insulin-Regulated Aminopeptidase by a Macrocyclic Peptidic Inhibitor12
Stereochemical Differences in Fluorocyclopropyl Amides Enable Tuning of Btk Inhibition and Off-Target Activity12
SJPYT-195: A Designed Nuclear Receptor Degrader That Functions as a Molecular Glue Degrader of GSPT112
Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation Inhibitors12
Recent Advances in Alchemical Binding Free Energy Calculations for Drug Discovery12
Discovery of Adamantane Carboxamides as Ebola Virus Cell Entry and Glycoprotein Inhibitors12
Accelerating Drug Discovery: Synthesis of Complex Chemotypes via Multicomponent Reactions11
Discovery of Small-Molecule CD33 Pre-mRNA Splicing Modulators11
Selective DYRK1A Inhibitor for the Treatment of Neurodegenerative Diseases: Alzheimer, Parkinson, Huntington, and Down Syndrome11
Novel Histone Deacetylase 6 Inhibitors for Treating Alzheimer’s Disease and Cancer11
Structure-Based Discovery of Proline-Derived Arginase Inhibitors with Improved Oral Bioavailability for Immuno-Oncology11
Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 3511
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation11
Discovery of a Selective, Covalent IRAK1 Inhibitor with Antiproliferative Activity in MYD88 Mutated B-Cell Lymphoma11
Relevance of the Trillion-Sized Chemical Space “eXplore” as a Source for Drug Discovery11
Redefining the Histone Deacetylase Inhibitor Pharmacophore: High Potency with No Zinc Cofactor Interaction11
Discovery of Antibacterial Contezolid Acefosamil: Innovative O-Acyl Phosphoramidate Prodrug for IV and Oral Therapies11
Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design11
Indole-Containing Pyrazino[2,1-b]quinazoline-3,6-diones Active against Plasmodium and Trypanosomatids11
Optimization of Versatile Oxindoles as Selective PI3Kδ Inhibitors11
Identification and Development of 1,4-Diaryl-1,2,3-triazolo-Based Ureas as Novel FLT3 Inhibitors11
N-Aromatic-Substituted Indazole Derivatives as Brain-Penetrant and Orally Bioavailable JNK3 Inhibitors11
Novel Histone Acetyltransferase (HAT) Inhibitors for Treating Diseases11
Biological Evaluation of 5′-(N-Ethylcarboxamido)adenosine Analogues as Grp94-Selective Inhibitors11
The Basicity Makes the Difference: Improved Canavanine-Derived Inhibitors of the Proprotein Convertase Furin11
Synthesis of HDAC Inhibitor Libraries via Microscale Workflow11
A New Highly Deuterated [18F]AV-45, [18F]D15FSP, for Imaging β-Amyloid Plaques in the Brain11
Novel Thienopyridines as RIPK2 Inhibitors for Treating Inflammatory Bowel Disease11
Novel Isoindolinone-Based Analogs of the Natural Cyclic Peptide Fenestin A: Synthesis and Antitumor Activity11
Discovery of Surfactins as Inhibitors of MicroRNA Processing Using Cat-ELCCA11
Novel Nitrile Peptidomimetics for Treating COVID-1911
Identification of Novel Rho-Kinase-II Inhibitors with Vasodilatory Activity11
BRD9 Bifunctional Degraders for Treating Cancer11
Polysaccharide-Based Nanoparticles for Two-Step Responsive Release of Antitumor Drug11
Identification of Inhibitors of Thrombospondin 1 Activation of TGF-β11
Sulfamoylbenzamide-based Capsid Assembly Modulators for Selective Inhibition of Hepatitis B Viral Replication11
Covalent Bridging of Corilagin Improves Antiferroptosis Activity: Comparison with 1,3,6-Tri-O-galloyl-β-d-glucopyranose11
Conjugation Ratio, Light Dose, and pH Affect the Stability of Panitumumab–IR700 for Near-Infrared Photoimmunotherapy11
Antitubercular Activity of Novel 2-(Quinoline-4-yloxy)acetamides with Improved Drug-Like Properties10
Dual-Target Inhibitors of the Folate Pathway Inhibit Intrinsically Trimethoprim-Resistant DfrB Dihydrofolate Reductases10
Fluorescent Probes for Ecto-5′-nucleotidase (CD73)10
Hydrophobic Tagging-Induced Degradation of PDEδ in Colon Cancer Cells10
Discovery of a Potent and Selective Covalent p300/CBP Inhibitor10
A Retrospective Look at the Impact of Binding Site Environment on the Optimization of TRPA1 Antagonists10
Structure-based Discovery of Cell-Potent Peptidomimetic Inhibitors for Protein N-Terminal Methyltransferase 110
SMARCA2/4 PROTAC for Targeted Protein Degradation and Cancer Therapy10
Structurally Optimized Potent Dual-Targeting NBTI Antibacterials with an Enhanced Bifurcated Halogen-Bonding Propensity10
Discovery of Potent Inhibitors of Streptococcus mutans Biofilm with Antivirulence Activity10
Lathyrane Diterpenoids as Novel hPXR Agonists: Isolation, Structural Modification, and Structure–Activity Relationships10
Novel Small Molecule RNA m6A Demethylase AlkBH5 Inhibitors for Treating Cancer10
Large-Scale Screening of Antifungal Peptides Based on Quantitative Structure–Activity Relationship10
Mining Public Domain Data to Develop Selective DYRK1A Inhibitors10
A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors10
Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum10
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity10
Discovery of 2,4-1H-Imidazole Carboxamides as Potent and Selective TAK1 Inhibitors10
Flavonol-Based Carbon Monoxide Delivery Molecule with Endoplasmic Reticulum, Mitochondria, And Lysosome Localization10
Identification, Synthesis, and Characterization of a Major Circulating Human Metabolite of TRPV4 Antagonist GSK279874510
Structure–Activity Relationship and In Silico Evaluation of cis- and trans-PCPA-Derived Inhibitors of LSD1 and LSD210
The Compelling Demand for an Effective PrPC-Directed Therapy against Prion Diseases10
Discovery by Virtual Screening of an Inhibitor of CDK5-Mediated PPARγ Phosphorylation10
Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer10
2-Trifluoromethylthiazole-5-carboxamides: Analogues of a Stilbene-Based Anti-HIV Agent that Impact HIV mRNA Processing10
Escaping from Flatland: Antimalarial Activity of sp3-Rich Bridged Pyrrolidine Derivatives10
Vinyl Sulfone-Based Inhibitors of Nonstructural Protein 2 Block the Replication of Venezuelan Equine Encephalitis Virus10
Discovery of a Pyrimidothiazolodiazepinone as a Potent and Selective Focal Adhesion Kinase (FAK) Inhibitor10
Exploration of a 14-3-3 PPI Pocket by Covalent Fragments as Stabilizers10
Discovery of Futibatinib: The First Covalent FGFR Kinase Inhibitor in Clinical Use10
Virtual Screening Approach to Identifying a Novel and Tractable Series of Pseudomonas aeruginosa Elastase Inhibitors10
Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu7 Positive Allosteric Modulator Tool Compound10
Design, Synthesis, and Biological Evaluation of Novel 1,3-Oxazole Sulfonamides as Tubulin Polymerization Inhibitors10
In Silico Targeting of the Long Noncoding RNA MALAT110
Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors10
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field10
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain10
Amide–Amine Replacement in Indole-2-carboxamides Yields Potent Mycobactericidal Agents with Improved Water Solubility10
Discovery and SAR of Novel Disubstituted Quinazolines as Dual PI3Kalpha/mTOR Inhibitors Targeting Breast Cancer9
Fragment Ligands of the m6A-RNA Reader YTHDF29
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity9
Derivatization Design of Synthetically Accessible Space for Optimization: In Silico Synthesis vs Deep Generative Design9
Discovery of Imidazopyridines as Potent Inhibitors of Indoleamine 2,3-Dioxygenase 1 for Cancer Immunotherapy9
Structure-Based Design of A-1293102, a Potent and Selective BCL-XL Inhibitor9
Novel 2-Aryloxazoline Compounds Exhibit an Inhibitory Effect on Candida spp., Including Antifungal-Resistant Isolates9
Investigation on the Anticancer Activity of Symmetric and Unsymmetric Cyclic Sulfamides9
Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies9
Discovery of Arylsulfonamide Nav1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile9
Reducing the Toxicity of Designer Aminoglycosides as Nonsense Mutation Readthrough Agents for Therapeutic Targets9
Efficient NMR Screening Approach to Discover Small Molecule Fragments Binding Structured RNA9
Synthesis and Evaluation of Neutral Phosphate Triester Backbone-Modified siRNAs9
Design and Synthesis of Oleanolic Acid Trimers to Enhance Inhibition of Influenza Virus Entry9
Structure–Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors9
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors9
Substituted 2,3-Benzodiazepines Derivatives as Bromodomain BRD4 Inhibitors9
Design and Synthesis of Tranylcypromine-Derived LSD1 Inhibitors with Improved hERG and Microsomal Stability Profiles9
Synthesis, Anti-Plasmodial Activities, and Mechanistic Insights of 4-Aminoquinoline-Triazolopyrimidine Hybrids9
Identification and Evaluation of Brominated Carbazoles as a Novel Antibiotic Adjuvant Scaffold in MRSA9
Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors9
0.045192003250122